Progesterone prepares your uterine lining to receive an embryo and sustains early pregnancy. In IVF, your body can’t produce enough of it on its own, so supplemental progesterone is a standard part of nearly every cycle. It thickens the lining, opens the window when implantation can happen, and keeps the uterus calm enough for an embryo to settle in.
Why Your Body Needs Extra Progesterone During IVF
In a natural menstrual cycle, progesterone comes from the corpus luteum, a temporary structure that forms in the ovary after you ovulate. It produces enough progesterone to sustain early pregnancy until the placenta takes over. IVF disrupts this process in two different ways depending on the type of cycle you’re doing.
In a fresh transfer cycle, your ovaries develop multiple follicles instead of one. After egg retrieval, you may form several corpus luteum structures, but the medications used to prevent premature ovulation (GnRH agonists or antagonists) suppress the brain signals that keep those structures functioning. The high levels of estrogen and progesterone from multiple corpus luteum structures also feed back to the brain and further suppress luteinizing hormone, the signal the corpus luteum needs to keep producing progesterone. The result is a luteal phase deficiency: your body makes some progesterone but not reliably enough.
In a medicated frozen embryo transfer, the gap is even more straightforward. Your natural cycle is suppressed entirely, and you take estrogen to build the lining from scratch. There is no ovulation, no corpus luteum, and therefore no natural progesterone at all. Every bit of it must come from supplementation.
How Progesterone Changes the Uterine Lining
Estrogen handles the first phase of preparation, causing the uterine lining to thicken and grow new blood vessels and glands. But a thick lining alone isn’t enough. Progesterone triggers a transformation called decidualization, where the cells of the lining change their structure and behavior to become receptive to an embryo. The lining develops more glands, produces nutritive secretions, and creates the cellular environment needed for an embryo to implant and for a placenta to begin forming.
Without adequate progesterone exposure, the lining looks ready on an ultrasound but is functionally unable to support implantation.
Setting the Window of Implantation
The uterine lining is only receptive to an embryo for a limited stretch of time, typically a span of about 24 to 48 hours. Progesterone is what opens this window. In a medicated frozen transfer, the day you start progesterone is counted as “P+0,” and most clinics schedule a blastocyst transfer on day five of progesterone exposure (P+5), with a typical range of P+4 to P+6.
This timing matters more than most patients realize. If the embryo arrives when the lining isn’t yet receptive, or after the window has closed, implantation fails regardless of embryo quality. Some clinics offer endometrial receptivity testing to personalize the exact transfer day, but the standard P+5 protocol works well for the majority of patients.
Calming Uterine Contractions
Progesterone also quiets the muscular wall of the uterus. During the luteal phase, rising progesterone levels decrease the frequency and strength of uterine contractions. This matters because contractions after embryo transfer can physically displace the embryo from where it was placed. Research on transfer depth and pregnancy rates has shown that when progesterone levels are adequate, embryos are more likely to stay near their initial placement, which improves the chances of successful implantation.
Target Progesterone Levels
Your clinic will likely check your blood progesterone level around the day of transfer. For frozen embryo transfers, a serum level between 10 and 20 ng/mL on transfer day is associated with the best outcomes. A study of single euploid (chromosomally normal) embryo transfers found that live birth rates were highest when progesterone was in the 10 to 15 ng/mL range (70%) and declined as levels climbed: 62% at 15 to 20, 52% at 20 to 30, and down to 33% above 40 ng/mL. Levels above 20 ng/mL were associated with lower live birth rates and higher pregnancy loss.
If your levels come back too low before transfer, your clinic may adjust your dose or delay the transfer. Too high is also a concern, which is why monitoring matters.
How Progesterone Is Taken
The two most common routes are intramuscular injections (progesterone in oil) and vaginal preparations (suppositories, inserts, or gel). Both are effective, and the choice often comes down to your comfort and your clinic’s protocol.
- Intramuscular injections deliver progesterone into the bloodstream through a daily shot, typically in the upper outer quadrant of the buttock. The most common side effects are pain, soreness, and occasionally inflammation at the injection site. A standard dose is 50 mg daily, though protocols vary.
- Vaginal progesterone is absorbed directly through the cervix and reaches high concentrations in the uterus without needing to circulate through the entire bloodstream first. This “first uterine pass” effect means it can achieve strong local levels with lower systemic exposure. Most patients find it more tolerable than injections.
In terms of pregnancy rates, the two routes perform similarly overall. Clinical pregnancy rates in one large comparison were 49% with vaginal progesterone and 44% with intramuscular, a difference that was not statistically significant. Some clinics use a combination of both, particularly in frozen transfer cycles where there is no natural progesterone production at all.
When You Start and When You Stop
In a medicated frozen transfer, you’ll start progesterone after your lining has been built up with estrogen to at least 7 or 8 mm. Transfer is then timed to align with your window of implantation, usually five days later for a blastocyst.
In a fresh transfer cycle, progesterone supplementation typically begins the day after egg retrieval, since that’s when the luteal phase would naturally start.
How long you continue depends on your clinic. Some protocols call for progesterone through 10 to 12 weeks of pregnancy, when the placenta fully takes over production. Others discontinue earlier. One retrospective study compared stopping progesterone after a positive pregnancy test (around 4 weeks of pregnancy) versus continuing through 12 weeks. Both groups had the same live birth rate, around 75 to 77%, suggesting that extended supplementation may not improve final outcomes. However, many clinics still continue through the first trimester as a precaution, particularly after frozen transfers where there was no corpus luteum at all.
Stopping progesterone can feel nerve-wracking, but the placenta begins producing its own progesterone as early as 7 to 8 weeks of gestation. By 10 to 12 weeks, it is fully self-sufficient. Your clinic will guide you on when to taper or stop based on your specific cycle type and hormone levels.